Digital Medicine is promising to revolutionize healthcare delivery and transform the practice of medicine by introducing a new class of digital therapeutics and combination products; enabling patient-centric clinical trials and research with digital biomarkers and real-world evidence; and taking precision health to the next level by allowing continuous real-time patient monitoring with sensors and wearables, improved Rx adherence, and Artificial Intelligence-enabled patient management. CHI’s Second Annual Digital Medicine Congress brings together digital health thought leaders and executives from pharma and tech companies, academics and clinicians, healthcare providers, payors, investors, and entrepreneurs for a comprehensive 4-track program and facilitated networking opportunities, aimed to foster collaboration and innovation in digital medicine.
